Betta Pharmaceuticals Co Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Betta Pharmaceuticals Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014312
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Betta Pharmaceuticals Co Ltd (Betta Pharma) is a developer and manufacturer of drugs for treating cancer, cardiovascular diseases and diabetes. The company’s product includes conmana, a selective epidermal growth factor receptor tyrosine kinase inhibitor indicated for treating locally advanced or metastatic non-small cell lung cancer. It performs research of drugs at its research and development center located in Beijing including synthesis lab, analytical lab, pharmacology lab, formulation lab, medical department, and an intellectual property department. The company operates in Hangzhou and Beijing, China. Beta Pharma is headquartered in Hangzhou, China.

Betta Pharmaceuticals Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Betta Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Betta Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Betta Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Betta Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Betta Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Betta Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Betta Pharma Enters into Agreement with Hangzhou-Based Genetic Technology Company 10
Amgen Forms Joint Venture With Zhejiang Beta Pharma 11
Equity Offering 13
Beijing Biostar Technologies Plans to Raise USD7.3 Million in Private Placement of Shares 13
Acquisition 14
Betta Pharma to Acquire Remaining 50% Stake in Equinox Science for USD15 Million 14
Betta Pharma Acquires Remaining 22.6% Stake in AnewPharma for USD16 Million 15
Betta Pharma Plans to Acquire 77.4% Stake in AnewPharma for USD54 Million 16
Betta Pharma to Invest USD20 Million in Xcovery 17
Betta Pharmaceuticals Co Ltd – Key Competitors 18
Betta Pharmaceuticals Co Ltd – Key Employees 19
Betta Pharmaceuticals Co Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Betta Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Betta Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Betta Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Betta Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Betta Pharmaceuticals Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Betta Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Betta Pharma Enters into Agreement with Hangzhou-Based Genetic Technology Company 10
Amgen Forms Joint Venture With Zhejiang Beta Pharma 11
Beijing Biostar Technologies Plans to Raise USD7.3 Million in Private Placement of Shares 13
Betta Pharma to Acquire Remaining 50% Stake in Equinox Science for USD15 Million 14
Betta Pharma Acquires Remaining 22.6% Stake in AnewPharma for USD16 Million 15
Betta Pharma Plans to Acquire 77.4% Stake in AnewPharma for USD54 Million 16
Betta Pharma to Invest USD20 Million in Xcovery 17
Betta Pharmaceuticals Co Ltd, Key Competitors 18
Betta Pharmaceuticals Co Ltd, Key Employees 19
Betta Pharmaceuticals Co Ltd, Other Locations 20
Betta Pharmaceuticals Co Ltd, Joint Venture 20

★海外企業調査レポート[Betta Pharmaceuticals Co Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bharat Heavy Electricals Ltd (BHEL)-エネルギー分野:企業M&A・提携分析
    Summary Bharat Heavy Electricals Limited (BHEL) is an integrated power plant equipment manufacturer that designs, manufactures, constructs, tests, commissions and services a broad range of products. Its product portfolio includes transformers, valves and oil field equipment, electrostatic precipitat …
  • Indequity Group Limited:企業の戦略・SWOT・財務分析
    Indequity Group Limited - Strategy, SWOT and Corporate Finance Report Summary Indequity Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Fidelity National Information Services, Inc.:企業のM&A・事業提携・投資動向
    Fidelity National Information Services, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fidelity National Information Services, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, d …
  • ContraVir Pharmaceuticals Inc (CTRV)-製薬・医療分野:企業M&A・提携分析
    Summary ContraVir Pharmaceuticals Inc (ContraVir) is a biopharmaceutical company that focusses on development and commercialization of targeted antiviral therapies. The company’s pipeline product includes TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its …
  • DxTerity Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary DxTerity Diagnostics Inc (DxTerity) is a medical device company that offers molecular diagnostic solutions. The company develops genomic tests for disease diagnosis. Its patient clinical research platform and dxcollect fingerstick collection kit are used for population scale genomic studies. …
  • Mylan Laboratories Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Mylan Laboratories Ltd (Mylan), a subsidiary of Mylan NV is a pharmaceutical company that manufactures and supplies API products. The company offers HIV care products for the treatment of HIV/AIDS. It provides women’s care products for therapies such as hormone replacement therapy, infertili …
  • Urenco Ltd:企業の戦略・SWOT・財務情報
    Urenco Ltd - Strategy, SWOT and Corporate Finance Report Summary Urenco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • AstraZeneca Plc (AZN):医療機器:M&Aディール及び事業提携情報
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection a …
  • Cosmo Pharmaceuticals NV (COPN):企業の財務・戦略的SWOT分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Sensorion SA (ALSEN):企業の財務・戦略的SWOT分析
    Summary Sensorion SA (Sensorion) is a biopharmaceutical company that develops therapies. The company provides treatments for vestibular and cochlear pathologies. It develops drug candidates through its technology platform for the treatment of various therapeutic areas including vestibular neuritis, …
  • Fujifilm Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Fujifilm Corp (Fujifilm), a subsidiary of Fujifilm Holdings Corporation, is a provider of imaging and information solutions. The company’s product portfolio encompasses color films, optical devices, digital cameras, photofinishing equipment and color paper, chemicals and services for photofi …
  • Petron Corp (PCOR):企業の財務・戦略的SWOT分析
    Petron Corp (PCOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Urban One, Inc.:企業の戦略・SWOT・財務分析
    Urban One, Inc. - Strategy, SWOT and Corporate Finance Report Summary Urban One, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • The Nippon Synthetic Chemical Industry Co Ltd:企業の戦略的SWOT分析
    The Nippon Synthetic Chemical Industry Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Cardax Inc (CDXI):製薬・医療:M&Aディール及び事業提携情報
    Summary Cardax Inc (Cardax), formerly Cardax Pharmaceuticals Inc is a life science company that discovers and develops pharmaceutical and consumer health technologies. The company discovers and develops anti-inflammatory dietary supplements, small molecule therapies, medicinal products, and drug pro …
  • Discovery Communications, Inc.:企業の戦略・SWOT・財務分析
    Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Cloud Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cloud Pharmaceuticals Inc (Cloud Pharmaceuticals), formerly TeraDiscoveries Inc is a drug development company that designs and develops novel drugs and therapies for cancer, inflammation, CNS disorders, and rare diseases. The company offers molecular designs of ligands through its proprietar …
  • Harpoon Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Harpoon Therapeutics Inc (Harpoon Therapeutics) is a biotechnology company that offers solutions for immune-oncology diseases. The company provides products portfolio such as of HPN424, prostate specific antigen and harnesses a technology named TriTAC technology. It employs TriTAC technology …
  • PPG Industries Inc (PPG):企業の財務・戦略的SWOT分析
    PPG Industries Inc (PPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cintas Corp (CTAS):企業の財務・戦略的SWOT分析
    Cintas Corp (CTAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆